Pharmacological Modulation of Cocaine Effects - 1
NCT00000201 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
Selegiline
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
George Bigelow, Ph.D. · Johns Hopkins University
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2001-12-31
Countries
- United States
Study Locations
More Related Trials
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Infusion Laboratory: Protocol 1 - Selegeline - 2
NCT00000337 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1
NCT00033046 ·Status: UNKNOWN ·Phase: PHASE1
-
Alterations in Serotonergic Functions in Cocaine Addicts - 1
NCT00000312 ·Status: COMPLETED ·Phase: PHASE1
-
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 ·Status: COMPLETED
-
Improving Learning-based Treatment of Cocaine Dependence With Medication
NCT01526538 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil - Escitalopram Study for Cocaine Dependence
NCT01601730 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
NCT00032916 ·Status: UNKNOWN ·Phase: PHASE1
-
Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1
NCT00218387 ·Status: COMPLETED ·Phase: PHASE2
-
Carbamazepine Treatment for Cocaine Dependence - 5
NCT00000191 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
NCT00218036 ·Status: TERMINATED ·Phase: PHASE2
-
New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000271 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
NCT01067846 ·Status: COMPLETED ·Phase: NA
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals
NCT00218062 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence
NCT00123383 ·Status: UNKNOWN ·Phase: PHASE2
-
Complementary Combination Therapy for Cocaine Dependence
NCT02538744 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse
NCT01137890 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
IV Cocaine Abuse: A Laboratory Model - 1
NCT00000212 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
NCT00000217 ·Status: COMPLETED ·Phase: PHASE2
-
Serotonin, Impulsivity, and Cocaine Dependence Treatment
NCT00297505 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
NCT01495195 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a Non-Drug Choice on Cocaine Reinforcement
NCT01906346 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pharmacotherapy & CM for Opioid and Cocaine Dependence
NCT00838981 ·Status: COMPLETED ·Phase: PHASE1/PHASE2